This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved lecanemab, commercially known as Leqembi, in October 2025.
‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s
- 2026-05-04, 11:21 AM
- globalnews.ca
- 0
No comments